Basal glycemia and glycated hemoglobin, their role in the detection of abnormal glucose tolerance in relatives of patients with type 2 diabetes;Utilidad de la glucemia basal y de la hemoglobina glucosilada para la detección de la tolerancia anormal a la glucosa en familiares de pacientes con diabetes tipo 2

Medicina Clinica

Volumn 112, Issue 7, 1999, Pages 241-244

  Costa, Ángels ^a   Conget, Ignacio ^a,c   Treserras, Ricart ^b   Gomis, Ramon ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Dept de Sanitat I Seguretat Social ^*  (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; INSULIN;

ADULT; ARTICLE; BLOOD; DIET RESTRICTION; FEMALE; GENETICS; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NONPARAMETRIC TEST; REGRESSION ANALYSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; STATISTICS;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; MALE; MIDDLE AGED; REGRESSION ANALYSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 0033608262     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Departement de Sanitat i Seguritat Social. Prevalença de diabetis no insulinodependent a Catalunya. Butlletí Epidemiológic de Catalunya 1997; 18: 41-43.
2. Tamayo B, Faure E, Roche MJ, Rubio E, Sánchez E, Salvador JA. Prevalence of diabetes and impaired glucose tolerance in Aragón, Spain. Diabetes Care 1997; 20: 534-536.
3. Chiasson JL, Josse RG, Leiter LA, Mihic M, Nathan DM, Palmason C et al. The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance. Diabetes Care 1996; 19: 1.190-1.193.
4. Antonucci T, Whitcomb R, McLain R, Lockwood D. Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglitazone. Diabetes Care 1997; 20: 188-193.
5. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and diabetes study. Diabetes Care 1997; 20: 537-544.
6. Granner DK, O'Brien RM. Molecular physiology and genetics of NIDDM. Diabetes Care 1992; 15: 369-388.
7. Eriksson J, Franssila-Kallunki A, Ekstrand A, Sataranta C, Widén E, Schalin C et al. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 1989; 321: 337-343.
8. O'Rahilly S, Turner RC, Matthews DR. Impaired pulsatile secretion of insulin in relatives of patients with non-insulin dependent diabetes. N Engl J Med 1988; 318: 1.225-1.230.
9. Webwr B. Standardization of the oral glucose tolerance test. International Study for Diabetes Bulletin 1978; 2: 23-26.
10. World Health Organization. Diabetes mellitus. Report of a WHO study group. Geneva. World Health Organization, 1985 (Tech Rep Ser. n.o 727).
11. Mooy JM, Gootenhuis PA, De Vries H, Kostense PJ, Popp-Snidjers C, Bouter LM et al. Infra-individual variation of glucose, specific insulin and prainsulin concentrations measured by two oral glucose tolerance tests in general Caucasian population: the Hoorn study. Diabetologia 1996; 39: 298-305.
12. Knowler WC. Screening for NIDDM: opportunities for detection, treatment and prevention. Diabetes Care 1994; 17: 445-450.
13. McCance DR, Hanson RL, Charles MA, Jacobsson LT, Pettitt DJ, Bennett PH et al. Comparison of tests for glycated hemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. Br Med J 1994; 308: 1.323-1.328.
14. 1c levels for diagnosing diabetes: diagnostic criteria and performance revisited. Diabetes Care 1997; 20: 785-791.
15. Simon D, Coignet MC, Thibult N, Senan C, Eschwege E. Comparison of glycosilated hemoglobin and fasting plasma glucose with 2 hours postload glucose in the detection of diabetes mellitus. Am J Epidemiol 1985; 122: 589-593.
16. Venkat KM, Hanson RL, Pettitt DJ, Bennett PH, Knowler WC. A two-step strategy for identification of high-risk subjects for a clinical trial of prevention of NIDDM. Diabetes Care 1997; 19: 972-978.
17. Iglesias P, Diez JJ. Glucación no enzimática de proteinas en la dibetes mellitus. Med Clin (Barc) 1997; 108: 23-33.
18. McCance DR, Hanson RL, Charles MA, Jacobsson LTH, Pettitt DJ, Bennett PH et al. Which test for diagnosing diabetes? Diabetes Care 1995; 18: 1.042-1.044.
19. Peters AL, Davidson MB, Schriger DL, Hasselblad V. A clinical approach for the diagnosis of diabetes mellitus. An analysis using glycosylated hemoglobin levels. JAMA 1996; 276: 1.246-1.252.
20. The expert Committee on the Diagnosis and Clasification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1.183-1.197.
21. 1c. Diabet Med 1993; 10: 260-263.
22. Jarrett RJ. The cardiovascular risk associated with impaired glucose tolerance. Diabet Med 1996; 13 (Supl): 15-18.
23. Eastman RC, Cowie CC, Harris MI. Undiagnosed diabetes or impaired glucose tolerance and cardiovascular risk. Diabetes Care 1997; 20: 127-128.